While I have mixed feelings about The New York Times's coverage of certain topics these days, this is one topic where their reporting has (positively) shaped events. They had a big investigative piece earlier in the summer about pharmacy benefit managers: https://www.nytimes.com/2024/06/21/business/prescription-dru... And that likely led to the recent FTC announcements.